Ocugen Announces Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in U.S., Europe, and Japan

Stock Information for Ocugen, Inc.

Loading

Please wait while we load your information from QuoteMedia.